Johnston M - Search Results

1

Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor.

Kearon C, Ginsberg JS, Anderson DR, Kovacs MJ, Wells P, Julian JA, Mackinnon B, Demers C, Douketis J, Turpie AG, Van Nguyen P, Green D, Kassis J, Kahn SR, Solymoss S, Desjardins L, Geerts W, Johnston M, Weitz JI, Hirsh J, Gent M; SOFAST Investigators. Kearon C, et al. Among authors: johnston m. J Thromb Haemost. 2004 May;2(5):743-9. doi: 10.1046/j.1538-7836.2004.00698.x. J Thromb Haemost. 2004. PMID: 15099280 Free article. Clinical Trial.

2

Antiphospholipid antibodies and venous thromboembolism.

Ginsberg JS, Wells PS, Brill-Edwards P, Donovan D, Moffatt K, Johnston M, Stevens P, Hirsh J. Ginsberg JS, et al. Among authors: johnston m. Blood. 1995 Nov 15;86(10):3685-91. Blood. 1995. PMID: 7579334 Free article.

3

Free protein S deficiency may be found in patients with antiphospholipid antibodies who do not have systemic lupus erythematosus.

Crowther MA, Johnston M, Weitz J, Ginsberg JS. Crowther MA, et al. Among authors: johnston m. Thromb Haemost. 1996 Nov;76(5):689-91. Thromb Haemost. 1996. PMID: 8950774

4

The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literature.

Douketis JD, Gordon M, Johnston M, Julian JA, Adachi JR, Ginsberg JS. Douketis JD, et al. Among authors: johnston m. Thromb Res. 2000 Jul 1;99(1):25-34. doi: 10.1016/s0049-3848(00)00217-6. Thromb Res. 2000. PMID: 11012376

5

Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study.

Crowther MA, Roberts J, Roberts R, Johnston M, Stevens P, Skingley P, Patrassi GM, Sartori MT, Hirsh J, Prandoni P, Weitz JI, Gent M, Ginsberg JS. Crowther MA, et al. Among authors: johnston m. Thromb Haemost. 2001 Mar;85(3):390-4. Thromb Haemost. 2001. PMID: 11307802 Clinical Trial.

6

"ProC Global": a functional screening test that predicts recurrent venous thromboembolism.

Grand'Maison A, Bates SM, Johnston M, McRae S, Ginsberg JS. Grand'Maison A, et al. Among authors: johnston m. Thromb Haemost. 2005 Mar;93(3):600-4. doi: 10.1160/TH04-07-0445. Thromb Haemost. 2005. PMID: 15735816

7

An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition.

Demers C, Henderson P, Blajchman MA, Wells MJ, Mitchell L, Johnston M, Ofosu FA, Fernandez-Rachubinski F, Andrew M, Hirsh J, et al. Demers C, et al. Among authors: johnston m. Thromb Haemost. 1993 Mar 1;69(3):231-5. Thromb Haemost. 1993. PMID: 8470046

8

Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state.

Ginsberg JS, Demers C, Brill-Edwards P, Johnston M, Bona R, Burrows RF, Weitz J, Denburg JA. Ginsberg JS, et al. Among authors: johnston m. Blood. 1993 Jun 1;81(11):2958-63. Blood. 1993. PMID: 8499632 Free article.

9

Establishing a therapeutic range for heparin therapy.

Brill-Edwards P, Ginsberg JS, Johnston M, Hirsh J. Brill-Edwards P, et al. Among authors: johnston m. Ann Intern Med. 1993 Jul 15;119(2):104-9. doi: 10.7326/0003-4819-119-2-199307150-00002. Ann Intern Med. 1993. PMID: 8512158

10

Evaluation of a soluble fibrin assay in patients with suspected deep vein thrombosis.

Ginsberg JS, Siragusa S, Douketis J, Johnston M, Moffat K, Stevens P, Brill-Edwards P, Panju A, Patel A. Ginsberg JS, et al. Among authors: johnston m. Thromb Haemost. 1995 Sep;74(3):833-6. Thromb Haemost. 1995. PMID: 8571306

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,810 results

Search Page